NCT03548935: STEP 1: Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
- State
- Completed
- Phase
- Phase 3
- People
- 1,961 taking part
- Started
- 4 Jun 2018
- Primary completion
- 30 Mar 2020
- Arms
- Semaglutide s.c. 2.4 mg once weekly
- Results
- Posted on the registry
- 4 Jun 2018: Trial started
- 7 Jun 2018: Trial registered
- 5 Mar 2021: Trial completed
- 11 Aug 2021: Trial results posted